G-6-PDH Normal Control (G-6-PDH CONTROL N), Catalogue Number PD2618 Product Usage: This product is intended for in vitro diagnostic use, in the quality control of Glucose-6-Phosphate Dehydrogenase in erythrocytes
Published May 8, 2019 · Recall initiated: April 3, 2019
Summary
FDA records medical device Class II recall Z-1255-2019, published May 8, 2019 and initiated April 3, 2019. Recalling firm: Randox Laboratories Ltd.; Status: Terminated; Reported quantity: 10 kits; Lot: Lot Numbers: 676PD 701PD 716PD. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The target values and ranges in these lots are incorrect.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Randox Laboratories Ltd.
- Distributor
- The products were distributed to the following US states: IL, OH, NC, PA, WI, WV and Puerto Rico.
- Lot
- Lot Numbers: 676PD 701PD 716PD
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Ireland
Related recalls
- FDARX Series CYSC- Cystatin C Reagent -Intended for in vitro diagnostic (IVD) use as Randox Cystatin C assay onJuly 31, 2024
- FDAClinical Chemistry Calibration Serum (Catalog number Cal2351) that is 20x5ml lyophilized human based serumMay 15, 2024
- FDAEvidence MultiSTAT with software v 3.7-Analyzer intended for the qualitative determination of parent drugMay 15, 2024
- FDAMicroalbumin Calibrator Series (mALB CAL)-IVD used to calibrate the Microalbumin Assay Catalog Number: MA1567April 24, 2024
- FDACAROLINA(R) LIQUID CHEMISTRIES CORP. ETHA RGT. KIT, IVD, REF ST321May 8, 2019
- FDADiscovery NM/CT 670 DR Product Usage: The GE Discovery NM/CT 670 system is a medical tool intended for use byMay 8, 2019
Questions about this recall
Was G-6-PDH Normal Control (G-6-PDH CONTROL N), Catalogue Number PD2618 Product Usage: This product is intended for in vitro diagnostic use, in the quality control of Glucose-6-Phosphate Dehydrogenase in erythrocytes recalled?
Yes. FDA published recall Z-1255-2019 on May 8, 2019. Reported hazard: The target values and ranges in these lots are incorrect.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail